Pseudoephedrine-Benefits and Risks

被引：38

作者：

Glowacka, Krystyna ^{[1
]}

Wiela-Hojenska, Anna ^{[1
]}

机构：

[1] Wroclaw Med Univ, Dept Clin Pharmacol, Borowska 211a St, PL-50556 Wroclaw, Poland

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 10期

关键词：

pseudoephedrine; sympathomimetic; adverse reactions; non-medical use; EPHEDRINE; PHARMACOKINETICS; STEREOCHEMISTRY; METHCATHINONE; PERFORMANCE; EXPOSURE; UPDATE; USERS;

D O I：

10.3390/ijms22105146

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Pseudoephedrine (PSE) is a drug with a long history of medical use; it is helpful in treating symptoms of the common cold and flu, sinusitis, asthma, and bronchitis. Due to its central nervous system (CNS) stimulant properties and structural similarity to amphetamine, it is also used for non-medical purposes. The substance is taken as an appetite reducer, an agent which eliminates drowsiness and fatigue, to improve concentration and as a doping agent. Due to its easier availability, it is sometimes used as a substitute for amphetamine or methamphetamine. Pseudoephedrine is also a substrate (precursor) used in the production of these drugs. Time will tell whether legal restrictions on the sale of this drug will reduce the scale of the problem associated with its misuse.

引用

页数：11

共 43 条

[1] Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therapy [J].

Akay, Serhat ;

Ozdemir, Metehan .

CANADIAN JOURNAL OF CARDIOLOGY, 2008, 24 (11) :E86-E88

[2]

[Anonymous], 2015, BMJ Open Sport Exerc. Med, DOI [10.1136/bmjsem-2015-000066, DOI 10.1136/BMJSEM-2015-000066]

[3]

[Anonymous], 2013, S AFR J SM, DOI DOI 10.17159/2078-516X/2013/V25I2A374

[4] Pseudoephedrine Induced Ischemic Colitis: A Case Report and Review of Literature [J].

Aziz, Muhammad ;

Pervez, Asad ;

Fatima, Rawish ;

Bansal, Ajay .

CASE REPORTS IN GASTROINTESTINAL MEDICINE, 2018, 2018

[5] Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers [J].

Azzaro, Albert J. ;

VanDenBerg, Chad M. ;

Ziemniak, John ;

Kemper, Eva M. ;

Blob, Lawrence F. ;

Campbell, Bryan J. .

JOURNAL OF CLINICAL PHARMACOLOGY, 2007, 47 (08) :978-990

[6] Determination of urinary concentrations of pseudoephedrine and cathine after therapeutic administration of pseudoephedrine-containing medications to healthy subjects: implications for doping control analysis of these stimulants banned in sport [J].

Barroso, Osquel ;

Goudreault, Danielle ;

Carbo Banus, Marcel-li ;

Ayotte, Christiane ;

Mazzoni, Irene ;

Boghosian, Thierry ;

Rabin, Olivier .

DRUG TESTING AND ANALYSIS, 2012, 4 (05) :320-329

[7] Cough mixture dependence and stroke: implications for pseudoephedrine regulation [J].

Bharatula, Ajay ;

New, Peter W. .

MEDICAL JOURNAL OF AUSTRALIA, 2011, 194 (08) :427-427

[8] The advent of a new pseudoephedrine product to combat methamphetamine abuse [J].

Brzeczko, Albert W. ;

Leech, Ronald ;

Stark, Jeffrey G. .

AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2013, 39 (05) :284-290

[9]

Bucci LR, 2000, AM J CLIN NUTR, V72, p624S, DOI 10.1093/ajcn/72.2.624S

[10] ST Elevation Myocardial Infarction Presenting After Use of Pseudoephedrine [J].

Celik, Atac .

CARDIOVASCULAR TOXICOLOGY, 2009, 9 (02) :103-104

← 1 2 3 4 5 →